A Pilot Study of CYP2D6 Screening for Adverse Drug Reactions to Hydrocodone in Breast Milk

D
David Haas, MD

Primary Investigator

J
Jessica MacLean

Primary Investigator

Overview

The purpose of this study is to see if differences in your DNA (the blueprints or genetic material in your body) may play a role in how well pain medication works for you after surgery and if it plays a role in your baby?s behaviors when breast feeding

Description

This is a prospective pilot study in 100 consenting women. All women will be consented prior to non-emergent cesarean section. The women and their infants will undergo noninvasive genetic testing for drug metabolizing enzyme pathway genotypes. This is a n

Eligibility

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Drug Reactions
  • Age: Between 18 Years - 100 Years
  • Gender: Female
Updated on 20 Nov 2022. Study ID: 1109006811

Interested in the study?

Select a study center that’s convenient for you, and get in touch with the study team.

Contact a study center